U.S. Apollo, Blackstone, Hershey
Aug 13 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Apollo, Blackstone and Hershey, on Tuesday.
HIGHLIGHTS
* Apollo APO.N: Jefferies cuts target price to $114 from $129 |
* Blackstone BX.N: Jefferies raises target price to $147 from $138 |
* Hershey Co HSY.N: Goldman Sachs initiates coverage with sell rating |
* Palomar Holdings Inc PLMR.O: KBW raises target price to $113 from $96 |
* Walmart WMT.N: CFRA raises target price by $3 to $75 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* 10X Genomics Inc TXG.O: Morgan Stanley cuts target price to $46.00 from $50.00 |
* 10X Genomics Inc TXG.O: UBS cuts target price to $25 from $30 |
* Academy Sports and Outdoors Inc ASO.O: TD Cowen cuts target price to $54 from $58 |
* Academy Sports and Outdoors Inc ASO.O: TD Cowen cuts to hold from buy |
* Academy Sports and Outdoors Inc ASO.O: Wells Fargo cuts target price to $46 from $55 |
* Adverum Biotechnologies Inc ADVM.O: RBC cuts target price to $12 from $15 |
* AIG AIG.N: Jefferies cuts target price to $82 from $84 |
* AIG AIG.N: TD Cowen cuts target price to $80 from $83 |
* Airsculpt Technologies Inc AIRS.O: Leerink Partners cuts PT to $3.75 from $5 |
* Akamai Technologies Inc AKAM.O: D.A. Davidson raises target price to $120 from $115 |
* Akoya Biosciences Inc AKYA.O: Piper Sandler cuts target price to $4 from $6 |
* Alarm.com Holdings Inc ALRM.O: JP Morgan cuts target price to $65 from $70 |
* Alta Equipment Group Inc ALTG.N: D.A. Davidson cuts target price to $12 from $20 |
* AMC Networks Inc AMCX.O: TD Cowen cuts target price to $11 from $16 |
* American Public Education Inc APEI.O: Truist Securities cuts target to $15 from $20 |
* Amprius Technologies Inc AMPX.N: Northland Capital cuts target price to $4 from $10 |
* Antero Resources Corp AR.N: BMO cuts target price to $33 from $36 |
* Apellis Pharmaceuticals Inc APLS.O: JP Morgan cuts target price to $64 from $72 |
* Apollo APO.N: Jefferies cuts target price to $114 from $129 |
* Aramark ARMK.N: Citigroup raises target price to $40.50 from $36.50 |
* Ardent Health Partners Inc ARDT.N: Stephens initiates coverage with overweight rating |
* Ardent Health Partners Inc ARDT.N: Stephens initiates coverage with price target $24 |
* Ares Management Corp ARES.N: Jefferies cuts target price to $137 from $139 |
* ARS Pharmaceuticals Inc SPRY.O: Raymond James raises target price to $22 from $18 |
* ARS Pharmaceuticals Inc SPRY.O: Raymond James raises to strong buy from outperform |
* Arthur J. Gallagher & Co. AJG.N: TD Cowen raises target price to $288 from $273 |
* Artiva Biotherapeutics Inc ARTV.O: Needham initiates with buy rating; PT $23 |
* Artiva Biotherapeutics Inc ARTV.O: TD Cowen initiates coverage with buy rating |
* Artiva Biotherapeutics Inc ARTV.O: Wedbush initiates with outperform rating; PT $18 |
* Arvinas Inc ARVN.O: Citigroup cuts target price to $30 from $38 |
* Assurant Inc AIZ.N: UBS raises target price to $217 from $210 |
* Astria Therapeutics ATXS.O: Oppenheimer raises target price to $26 from $25 |
* Atea Pharmaceuticals Inc AVIR.O: Morgan Stanley raises PT to $6.88 from $2.00 |
* Atea Pharmaceuticals Inc AVIR.O: Morgan Stanley raises to equal-weight from underweight |
* Azek Company Inc AZEK.N: JP Morgan cuts target price to $48 from $52 |
* Baker Hughes Co BKR.O: BMO raises target price to $43 from $40 |
* Baldwin Insurance Group Inc BWIN.O: UBS raises target price to $49 from $43 |
* Belite Bio, Inc BLTE.O: H.C. Wainwright raises target price to $60 from $59 |
* Biohaven Ltd BHVN.N: UBS cuts target price to $54 from $55 |
* Bioventus Inc BVS.O: Canaccord Genuity raises target price to $12 from $8 |
* Blackstone BX.N: Jefferies raises target price to $147 from $138 |
* Boundless Bio Inc BOLD.O: Guggenheim cuts target price to $20 from $24 |
* Boundless Bio Inc BOLD.O: Leerink Partners cuts target price to $21 from $25 |
* Broadwind Inc BWEN.O: Craig-Hallum cuts target price to $4 from $5 |
* Bsr Real Estate Investment Trust HOMu.TO: BMO raises PT to $14.50 from $13.50 |
* Cambium Networks Corp CMBM.O: Jefferies cuts target price to $1.75 from $4 |
* Cannae Holdings Inc CNNE.N: Stephens cuts target price to $28 from $31 |
* Carlyle Group Inc CG.O: Jefferies cuts target price to $44 from $45 |
* Centerpoint Energy CNP.N: Wells Fargo cuts to equal weight from overweight |
* Centerpoint Energy, Inc. CNP.N: Wells Fargo cuts target price to $28 from $32 |
* Charles River Laboratories International CRL.N: Mizuho cuts target to $210 from $235 |
* Chevron Corp CVX.N: BMO cuts target price to $160 from $175 |
* Chord Energy Corp CHRD.O: BMO cuts target price to $205 from $220 |
* Civitas Resources Inc CIVI.N: BMO cuts target price to $75 from $82 |
* Clearway Energy Inc CWEN.N: RBC raises target price to $30 from $26 |
* Cogent Communications Holdings CCOI.O: BofA Global Research raises PT to $75 from $70 |
* Coherent Corp COHR.N: Stifel raises target price to $75 from $68 |
* CommScope Holding Company Inc COMM.O: Jefferies raises PT to $2.50 from $1 |
* Compass Therapeutics Inc CMPX.O: Leerink Partners cuts target price to $5 from $10 |
* Conagra Brands Inc CAG.N: Goldman Sachs initiates coverage with buy rating |
* Conagra Brands Inc CAG.N: Goldman Sachs initiates coverage with target price $36 |
* Conocophillips COP.N: BMO cuts target price to $123 from $130 |
* Constellation Energy Corp CEG.O: RBC cuts target price to $214 from $218 |
* Construction Partners Inc ROAD.O: D.A. Davidson raises target price to $55 from $50 |
* Coterra Energy Inc CTRA.N: BMO cuts target price to $32 from $33 |
* Crown Castle Inc CCI.N: BofA Global Research raises price objective to $115 from $110 |
* CVR Energy Inc CVI.N: UBS cuts target price to $30 from $33.75 |
* CVS Health Corp CVS.N: Mizuho cuts target price to $66 from $72 |
* Cytek Biosciences Inc CTKB.O: Piper Sandler cuts target price to $8 from $8.5 |
* Danimer Scientific Inc DNMR.N: TD Cowen cuts target price to $1 from $2 |
* Danimer Scientific Inc DNMR.N: TD Cowen cuts to hold from buy |
* Deere & Co DE.N: JP Morgan cuts target price to $360 from $375 |
* Dell Technologies Inc DELL.N: Barclays raises to equal weight from underweight |
* Devon Energy Corp DVN.N: BMO cuts target price to $52 from $55 |
* Diamondback Energy Inc FANG.O: UBS cuts target price to $245 from $257 |
* Dick's Sporting Goods, Inc. DKS.N: Wells Fargo cuts target price to $227 from $230 |
* Digital Realty Trust Inc DLR.N: Truist Securities raises PT to $168 from $160 |
* Draftkings Inc DKNG.O: Morgan Stanley cuts target price to $47.00 from $51.00 |
* Duke Energy Corp DUK.N: RBC raises target price to $119 from $113 |
* Dyne Therapeutics Inc DYN.O: Chardan Capital Markets raises PT to $50 from $42 |
* Dyne Therapeutics Inc DYN.O: H.C. Wainwright raises target price to $55 from $48 |
* Dyne Therapeutics Inc DYN.O: Jefferies raises target price to $50 from $42 |
* Dyne Therapeutics Inc DYN.O: Piper Sandler raises target price to $53 from $43 |
* Echostar Corp SATS.O: UBS raises target price to $15 from $14 |
* Envestnet Inc ENV.N: Jefferies raises target price to $63.15 from $59 |
* EOG Resources Inc EOG.N: BMO raises target price to $140 from $137 |
* EQT Corp EQT.N: BMO cuts target price to $39 from $45 |
* Equinix EQIX.O: Deutsche Bank raises target price to $910 from $880 |
* Esperion Therapeutics Inc ESPR.O: Needham cuts target price to $6 from $8 |
* Exxon Mobil XOM.N: BMO raises target price to $127 from $125 |
* Eyepoint Pharmaceuticals Inc EYPT.O: JP Morgan cuts target price to $29 from $32 |
* Fortrea Holdings Inc FTRE.O: Citigroup cuts target price to $30 from $42 |
* Fortrea Holdings Inc FTRE.O: Evercore ISI cuts target price to $22 from $27 |
* Fortrea Holdings Inc FTRE.O: Jefferies cuts target price to $25 from $32 |
* Fortrea Holdings Inc FTRE.O: Mizuho cuts target price to $22 from $27 |
* Fortrea Holdings Inc FTRE.O: TD Cowen cuts target price to $23 from $27 |
* General Mills GIS.N: Goldman Sachs initiates coverage with buy rating |
* General Mills GIS.N: Goldman Sachs initiates coverage with target price $76 |
* Genprex Inc GNPX.O: Alliance Global Partners cuts target price to $7.50 from $8 |
* Getty Images Holdings Inc GETY.N: Citigroup cuts target price to $5 from $6 |
* Getty Images Holdings Inc GETY.N: Macquarie cuts target price to $3.5 from $4 |
* Gitlab Inc GTLB.O: Mizuho cuts target price to $58 from $62 |
* Glacier Bancorp Inc GBCI.N: Piper Sandler cuts target price to $38 from $39 |
* Guardant Health Inc GH.O: Piper Sandler raises target price to $34 from $30 |
* Halliburton Co HAL.N: BMO cuts target price to $40 from $44 |
* Hamilton Lane Inc HLNE.O: Morgan Stanley raises target price to $140 from $132 |
* Hanover Insurance Group Inc THG.N: KBW raises target price to $144 from $142 |
* Hershey Co HSY.N: Goldman Sachs initiates coverage with sell rating |
* Hershey Co HSY.N: Goldman Sachs initiates coverage with target price $185 |
* Hess HES.N: BMO cuts target price to $155 from $170 |
* HF Sinclair Corp DINO.N: BMO cuts target price to $57 from $60 |
* HF Sinclair Corp DINO.N: UBS cuts target price to $70 from $73 |
* Hilton Worldwide Holdings Inc HLT.N: CFRA cuts target price to $236 from $242 |
* Hilton Worldwide Holdings Inc HLT.N: Morgan Stanley cuts PT to $233 from $237 |
* Horace Mann Educators Corp HMN.N: KBW cuts target price to $39 from $40 |
* Hormel Foods Corp HRL.N: Citigroup raises target price to $37 from $33 |
* Hormel Foods Corp HRL.N: Citigroup raises to buy from neutral |
* Humacyte Inc HUMA.O: BTIG cuts target price to $10 from $11 |
* Idacorp Inc IDA.N: Mizuho raises target price to $102 from $99 |
* Illumina Inc ILMN.O: Piper Sandler cuts target price to $195 from $200 |
* Immunome Inc IMNM.O: Piper Sandler cuts target price to $23 from $27 |
* Immunovant Inc IMVT.O: UBS cuts target price to $41 from $42 |
* Inozyme pharma Inc INZY.O: Jefferies assumes coverage with buy rating |
* Inozyme pharma Inc INZY.O: Jefferies assumes coverage with target price $17 vs $16 |
* Jeld-Wen Holding Inc JELD.N: Jefferies cuts target price to $15 from $16 |
* Kellanova K.N: Goldman Sachs initiates coverage with neutral rating; PT $75 |
* Kemper Corp KMPR.N: UBS raises target price to $71 from $67 |
* Keycorp KEY.N: CFRA raises target price by $5 to $17 |
* Keycorp KEY.N: CFRA raises to hold from sell |
* Keycorp KEY.N: Citigroup raises target price to $19 from $18 |
* Keycorp KEY.N: Wedbush raises target price to $17 from $16 |
* Kilroy Realty Corp KRC.N: Jefferies cuts target price to $42 from $45 |
* KKR KKR.N: Jefferies raises target price to $130 from $126 |
* Kraft Heinz KHC.O: Goldman Sachs initiates coverage with sell rating |
* Kraft Heinz KHC.O: Goldman Sachs initiates coverage with target price $34 |
* Lexeo Therapeutics, Inc. LXEO.O: H.C. Wainwright cuts target price to $21 from $22 |
* Littelfuse Inc LFUS.O: Stifel raises target price to $280 from $270 |
* Littelfuse Inc LFUS.O: Stifel raises to buy from hold |
* Main Street Capital Corp. MAIN.N: Oppenheimer raises target price to $44 from $43 |
* Marathon Oil Corp MRO.N: BMO cuts target price to $29 from $30 |
* Marathon Oil Corp MRO.N: UBS cuts target price to $30 from $32 |
* Marathon Petroleum Corp MPC.N: BMO raises target price to $200 from $195 |
* Maravai Lifesciences MRVI.O: Morgan Stanley cuts target price to $10.00 from $11.00 |
* Maravai Lifesciences MRVI.O: Morgan Stanley cuts to equal-weight from overweight |
* Marriott International Inc MAR.O: UBS cuts target price to $244 from $267 |
* Matador Resources Co MTDR.N: BMO cuts target price to $75 from $79 |
* MeiraGTx Holdings Plc MGTX.O: RBC cuts target price to $9 from $11 |
* Meridianlink Inc MLNK.N: UBS raises target price to $18 from $17 |
* Mind Medicine (Mindmed) Inc MNMD.O: RBC cuts target price to $20 from $22 |
* Mondelez MDLZ.O: Goldman Sachs initiates coverage with buy rating |
* Mondelez MDLZ.O: Goldman Sachs initiates coverage with target price $80 |
* Morgan Stanley Direct Lending Fund MSDL.N: RBC cuts target price to $22 from $23 |
* Murphy Oil Corp MUR.N: BMO cuts target price to $42 from $50 |
* Murphy Oil Corp MUR.N: UBS cuts target price to $45 from $49 |
* Myriad Genetics Inc MYGN.O: Jefferies raises target price to $22 from $20 |
* Myriad Genetics Inc MYGN.O: Piper Sandler raises target price to $30 from $28 |
* Natera Inc NTRA.O: Morgan Stanley raises target price to $132.00 from $125.00 |
* Natera Inc NTRA.O: Piper Sandler raises target price to $150 from $120 |
* Neuronetics Inc STIM.O: Canaccord Genuity cuts target price to $3 from $6 |
* Neuronetics Inc STIM.O: William Blair cuts to market perform |
* Occidental Petroleum Corp OXY.N: BMO cuts target price to $70 from $75 |
* Occidental Petroleum Corp OXY.N: JP Morgan cuts target price to $71 from $73 |
* Occidental Petroleum Corp OXY.N: Stephens raises target price to $77 from $76 |
* Oric Pharmaceuticals ORIC.O: Oppenheimer cuts target price to $15 from $17 |
* Ovintiv Inc OVV.N: BMO cuts target price to $54 from $61 |
* Pacific Biosciences of California PACB.O: Stephens cuts PT to $2.50 from $3.50 |
* Pacira Biosciences Inc PCRX.O: Truist Securities cuts target price to $8 from $30 |
* Pacira Biosciences Inc PCRX.O: Truist Securities cuts to sell from buy |
* Pacs Group Inc PACS.N: Citigroup raises target price to $41 from $34 |
* Pacs Group Inc PACS.N: Oppenheimer raises target price to $40 from $32 |
* Pacs Group Inc PACS.N: Oppenheimer raises target price to $40 from $32 |
* Pacs Group Inc PACS.N: Stephens raises target price to $40 from $37 |
* Palo Alto Networks Inc PANW.O: Mizuho raises target price to $380 from $350 |
* Palo Alto Networks Inc PANW.O: UBS raises target price to $345 from $300 |
* Palomar Holdings Inc PLMR.O: KBW raises target price to $113 from $96 |
* Par Pacific Holdings Inc PARR.N: Mizuho cuts target price to $30 from $33 |
* Paycor HCM Inc PYCR.O: Truist Securities cuts target price to $20 from $33 |
* PBF Energy Inc PBF.N: BMO cuts target price to $42 from $50 |
* PBF Energy Inc PBF.N: UBS cuts target price to $44 from $57 |
* Permian Resources Corp PR.N: BMO cuts target price to $21 from $22 |
* Perspective Therapeutics CATX.A: Oppenheimer cuts target price to $17 from $19 |
* Phillips 66 PSX.N: BMO raises target price to $155 from $150 |
* Plymouth Industrial REIT Inc PLYM.N: Truist Securities raises target to $26 from $24 |
* Prudential Financial Inc PRU.N: UBS raises target price to $119 from $112 |
* Range Resources Corp RRC.N: BMO cuts target price to $33 from $38 |
* Replimune Group Inc REPL.O: JP Morgan cuts target price to $14 from $17 |
* Revance Therapeutics Inc RVNC.O: Guggenheim cuts to neutral from buy |
* Revance Therapeutics Inc RVNC.O: H.C. Wainwright cuts to neutral; raises PT to $6.6 |
* Revance Therapeutics Inc RVNC.O: Mizuho cuts target price to $6.66 from $8 |
* Revance Therapeutics Inc RVNC.O: Needham cuts to hold from buy |
* Revance Therapeutics Inc RVNC.O: Piper Sandler cuts to neutral from overweight |
* Revance Therapeutics Inc RVNC.O: Piper Sandler raises target price to $6.66 from $6 |
* Revance Therapeutics Inc RVNC.O: William Blair cuts to market perform |
* Rockwell Automation Inc ROK.N: Berenberg cuts target price to $250 from $270 |
* Root Inc ROOT.O: UBS cuts target price to $61 from $71 |
* Rubrik Inc RBRK.N: Mizuho cuts target price to $43 from $46 |
* RXO Inc RXO.N: Jefferies cuts target price to $31 from $33 |
* Ryan Specialty Holdings Inc RYAN.N: UBS raises target price to $76 from $67 |
* Savara Inc SVRA.O: Jefferies raises target price to $8.50 from $7 |
* Scpharmaceuticals Inc SCPH.O: Leerink Partners cuts target price to $20 from $22 |
* Seer Inc. SEER.O: Morgan Stanley cuts target price to $3.00 from $7.00 |
* Sharkninja Inc SN.N: BofA Global Research raises price objective to $110 from $100 |
* SM Energy Co SM.N: BMO cuts target price to $50 from $52 |
* Snowflake Inc SNOW.N: Mizuho cuts target price to $165 from $180 |
* Southwestern Energy Co SWN.N: BMO cuts target price to $7 from $8 |
* Starbucks SBUX.O: Piper Sandler raises target price to $103 from $85 |
* Starbucks SBUX.O: Piper Sandler raises to overweight from neutral |
* Starbucks SBUX.O: TD Cowen raises to buy from hold; raises target to $105 from $81 |
* Sun Communities Inc SUI.N: Truist Securities raises target price to $138 from $127 |
* Sunnova Energy International Inc NOVA.N: Guggenheim raises PT to $14 from $10 |
* Syros Pharmaceuticals Inc SYRS.O: Piper Sandler cuts target price to $5 from $13 |
* Syros Pharmaceuticals, Inc. SYRS.O: H.C. Wainwright cuts target price to $6 from $15 |
* Talos Energy Inc TALO.N: Stephens raises target price to $25 from $24 |
* Targa Resources Corp TRGP.N: RBC raises target price to $153 from $147 |
* Target Corp TGT.N: Stifel cuts target price to $147 from $170 |
* Taysha Gene Therapies Inc TSHA.O: Needham cuts target price to $6 from $7 |
* Tela Bio Inc TELA.O: Canaccord Genuity cuts target price to $12 from $14 |
* Tela Bio Inc TELA.O: Jefferies cuts target price to $14 from $18 |
* Tela Bio Inc TELA.O: Piper Sandler cuts target price to $8 from $10 |
* Telos Corp TLS.O: BMO cuts target price to $3 from $4 |
* TPG Inc TPG.O: Jefferies raises target price to $43 from $40 |
* TPG Inc TPG.O: Morgan Stanley raises target price to $55 from $52 |
* Transdigm Group Inc TDG.N: Jefferies cuts target price to $1,515 from $1,625 |
* Travere Therapeutics Inc TVTX.O: JP Morgan raises target price to $20 from $19 |
* Trubridge Inc TBRG.O: RBC raises target price to $14 from $13 |
* TTEC Holdings Inc TTEC.O: Canaccord Genuity cuts target price to $4.50 from $8 |
* TTEC Holdings Inc TTEC.O: Northland Capital cuts target price to $16 from $19 |
* Ultragenyx Pharmaceutical Inc RARE.O: Citigroup cuts target price to $111 from $118 |
* Unitil Corp UTL.N: RBC raises target price to $55 from $52 |
* Urgent.Ly Inc ULY.O: Needham cuts target price to $2 from $5 |
* US Foods Holding Corp USFD.N: CFRA cuts target price to $55 from $63 |
* US Foods Holding Corp USFD.N: CFRA cuts to hold from buy |
* US Foods Holding Corp USFD.N: JP Morgan raises target price to $60 from $58 |
* Vacasa VCSA.O: Deutsche Bank cuts target price to $2.50 from $6.50 |
* Vera Therapeutics Inc VERA.O: JP Morgan cuts target price to $62 from $65 |
* Veracyte Inc VCYT.O: Stephens raises target price to $34 from $32 |
* Veralto Corp VLTO.N: UBS initiates coverage with neutral rating and target price $118 |
* Verastem Inc VSTM.O: Truist Securities cuts target price to $15 from $18 |
* Vicarious Surgical RBOT.N: TD Cowen adjusts PT to $10 from $1.50 to reflect 1-for-30 reverse stock split |
* Victory Capital Holdings Inc VCTR.O: Morgan Stanley raises PT to $40.00 from $39.00 |
* Victory Capital Holdings Inc VCTR.O: RBC cuts target price to $55 from $56 |
* Vital Energy Inc VTLE.N: BMO cuts target price to $48 from $55 |
* Walmart WMT.N: CFRA raises target price by $3 to $75 |
* Walmart WMT.N: Stifel raises target price to $73 from $71 |
* Warner Bros Discovery Inc WBD.O: Bernstein cuts target price to $8 from $10 |
* Warner Bros Discovery Inc WBD.O: Bernstein cuts to market-perform from outperform |
* Warner Music Group Corp WMG.O: Deutsche Bank cuts target price to $36 from $42 |
* Westlake Corp WLK.N: BMO raises target price to $171 from $167 |
* Whitestone REIT WSR.N: Truist Securities raises target price to $15 from $14 |
* Xylem Inc XYL.N: UBS initiates coverage with buy rating and target price $165 |
* Y-Mabs Therapeutics Inc YMAB.O: BMO cuts target price to $25 from $26 |
* Y-Mabs Therapeutics Inc. YMAB.O: Morgan Stanley cuts PT to $11.00 from $12.00 |
* Zoom Video Communications Inc ZM.O: Citigroup cuts target price to $67 from $77 |
* Zscaler Inc ZS.O: Mizuho cuts target price to $210 from $220 |
(Compiled by Bengaluru Newsroom)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
